As of October 11, 2026, Cemex S.A.B. de C.V. Sponsored (CX) trades at $9.560. CleaRank Financial AI rates it Buy with a fair value of $15.00, 56.9% above the current price. Wall Street's consensus target is $15.00 across 15 analysts. RSI at 41 is in neutral territory, and the price is below its 50-day average of $10.54.
Cemex S.A.B. de C.V. Sponsored (CX)
Cemex S.A.B. de C.V. Sponsored NYSE
CX Price Analysis
Market Metrics
Peer Benchmarking
Valuation vs Sector (Basic Materials)
Performance vs XLB
Sector Position Analysis
CX Financial Performance
Revenue vs. Earnings
Annual
Quarterly
CX Analysis
- Monitor Cemex's ability to improve its profit margins and return on equity to align with sector averages, as this is a key area for fundamental improvement.
- Given the current technical downtrend and neutral RSI, consider waiting for a confirmed break above the 50-day or 200-day moving average before initiating new long positions.
- With moderate insider selling, it is prudent to maintain a disciplined risk-management approach, potentially employing stop-loss orders to protect against further downside.
Fifteen analysts cover Cemex with a consensus rating of 'Strong Buy' and a median price target of $15.00, suggesting significant upside potential from the current price.
Source: Wall Street AnalystsAnalysts project strong EPS growth of 54.4% for the current year and an average annual revenue growth of 16.8% over the next five years, indicating positive future prospects.
Source: Wall Street EstimatesInsiders have sold $425,600 worth of stock with no reported purchases, indicating a 'Moderate Sell Signal' which warrants caution.
Source: Insider TransactionsThe stock is trading below its 50-day and 200-day moving averages ($10.54 and $11.78), with negative MACD, suggesting a bearish short-term trend that could continue.
Source: Technical AnalysisKey Statistics
| Market Cap | 416.10B |
|---|---|
| P/E Ratio | 79.67 |
| EPS (TTM) | 0.1200 |
| Dividend Yield | 0.00% |
| 52 Week High | 13.67 |
| 52 Week Low | 8.73 |
Earnings & Growth Analysis
Key Risks
Technical Indicators
| RSI (14) | 41.09 |
|---|---|
| MACD | -0.31 |
| SMA 50 | 10.54 |
| SMA 200 | 11.78 |
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
How does any other asset move with CX? One year of daily closes, Pearson correlation.
CX Trade Plans
Specific entry, exit, and risk management levels
Long entry pick an entry style
Risk Management
Profit Targets (Based on Conservative Entry)
Growth of $10,000
A $10,000 investment in CX in October 2016 would be worth about $11,850 today, compared with about $36,479 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CX today could grow to about $15,044 by 2036 in the base case, with a bull case near $85,645 and a bear case around $2,642. Projections are statistical simulations, not guarantees.
CX Stock Price Prediction: 2030
CleaRank's simulation projects a price near $11.26 for CX by 2030 in the base case, from $9.56 today (1.2x over 4 years). The downside path ends near $3.75. These are outcomes of a Monte Carlo simulation run on CX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $5.75 | $9.96 | $17.26 |
| 2028 | $4.77 | $10.37 | $22.58 |
| 2029 | $4.17 | $10.81 | $28.01 |
| 2030 | $3.75 | $11.26 | $33.82 |
| 2031 | $3.43 | $11.73 | $40.11 |
| 2032 | $3.18 | $12.21 | $46.99 |
| 2033 | $2.97 | $12.72 | $54.52 |
| 2034 | $2.80 | $13.25 | $62.80 |
| 2035 | $2.65 | $13.81 | $71.89 |
| 2036 | $2.53 | $14.38 | $81.88 |
Method: 10,000 simulated price paths using CX's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
CX Insider Trading Analysis
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 28, 2026 | GONZALEZ HERRERA JESUS VICENTE
Officer
|
Sell | 35.0K | $425.6K |
| Jul 1, 2026 | MARTINEZ MERLA JAIME
Officer
|
Grant | 7.7K | - |
| Jun 15, 2026 | ECHAVEZ HERNANDEZ LUIS
Officer
|
Grant | 81.7K | - |
| Jun 15, 2026 | RAMIREZ CANTU ALEJANDRO ALBERTO
Officer
|
Grant | 30.5K | - |
| Jun 12, 2026 | GONZALEZ FLORES JOSE ANTONIO
Officer
|
Grant | 75.5K | - |
| May 1, 2026 | DOEHNER COBIAN MAURICIO
Officer
|
Grant | 38.3K | - |
| May 1, 2026 | MUGUIRO DOMINGUEZ JAIME
Chief Executive Officer
|
Grant | 333.6K | - |
| May 1, 2026 | SALDANA MADERO ROGER
Officer
|
Grant | 37.1K | - |
| May 1, 2026 | ZAMBRANO LOZANO ROGELIO
Director
|
Grant | 205.6K | - |
